Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

This document is complementary to an Expert Review Document on Optical Coherence
Tomography (OCT) for the study of coronary arteries and atherosclerosis. 1 The goal of this …

Objectives: This study sought to compare the risk of stent thrombosis among patients treated
with bare-metal stents (BMS), first-generation drug-eluting stents (G1-DES), and second …

Aims The efficacy of durable polymer drug-eluting stents (DES) is delivered at the expense
of delayed healing of the stented vessel. Biodegradable polymer DES aim to avoid this …

State-of-the-art drug-eluting metal stents are the gold standard for interventional treatment of
coronary artery disease. Although they overcome some disadvantages and limitations of …

Cardiovascular disease (CVD) has emerged as a severe illness worldwide. Currently, the
top ten causes of death in the world include ischemic heart disease according to the Global …

Background The effectiveness of durable polymer drug-eluting stents comes at the expense
of delayed arterial healing and subsequent late adverse events such as stent thrombosis …

Background Drug-eluting stents with durable biocompatible or biodegradable polymers
have been developed to address the risk of thrombosis associated with first-generation drug …

Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their
long-term safety, with particular reference to stent thrombosis. In an effort to address these …

Iterations in stent technologies, advances in pharmacotherapy, and awareness of the
implications of implantation techniques have markedly reduced the risk of stent failure, both …